Effects of compound salvia miltiorrhiza parenteral solution on platelet -activating factor (PAF) expression and blood coagulation function in acute lung injury (ALI) patients

Min XU,Liang HUANG,Min-yun LI,Chun-shui CAO,Guo-ming GUO,Yong JI,Xiao-jun HUANG
DOI: https://doi.org/10.3969/j.issn.1002-1949.2010.01.010
2010-01-01
Abstract:Objective To investigate the effects of compound salvia miitiorrhiza parenteral solution on PAF expression and blood coagulation function in ALI patients.Methods 40 patients of ALI were randomly divided into two groups: control group (20 cases) and treatment group (20 cases).The basic treatments of two groups included primary disease treatment, anti -infection, keeping the balance of water -electrolyte, adrenal corticalhormone treatment and mechanical ventilation.The treatment group was supernumerarily injected with compound salvia miltiorrhiza parenteral solution 20mL and 5% glucose solution injection 250mL for 3d.Serum PAF and thromboxane B_2(TXB_2) level, prothrombin time (PT), activated partial thromboplastin time (APTT), fibrin (Fib), parameter of blood platelets and blood gas analysis were measured before the treatment and 3 days after the treatment.PAF and TXB_2, PT, APTT, parameter of blood platelets and blood gas analysis of two groups were compared before and after the treatment.Results Compared with those before the treatment, the oxygenation were improved, PAF and TXB_2 level decreased, PT and APTT increased, Fib decreased and parameter of blood platelets improved in both groups after the treatment(P <0.01).Compared with control group, the oxygenation were improved, PAF and TXB_2 level decreased, PT and APTT increased, Fib increased and parameter of blood platelets improved in treatment group.however, the mortality between two groupshad no significant difference (P > 0.05).Conclusion Compound salvia miltiorrhiza parenteral solution could decrease the expression of serum PAF in ALI patients.It could also improve coagulation function of ALI and oxygenation.So, it could be a new approach for early clinical treatment of ALI.
What problem does this paper attempt to address?